InvestorsHub Logo
Followers 49
Posts 3257
Boards Moderated 0
Alias Born 10/28/2012

Re: None

Sunday, 10/18/2015 11:39:34 PM

Sunday, October 18, 2015 11:39:34 PM

Post# of 130503
Amarantus Diagnostics expected to come on strong to close out 2015.

http://www.ddn-news.com/index.php?newsarticle=9891

LymPro and MSPrecise CLIA certifications on tap. The DX strategic transaction will likely be the driver to allow Amarantus to close on the Georgetown assay option agreement.

Interesting couple months ahead....

GC just reiterated these milestones twice this month at conferences. Given past miss-steps I believe GC and team are fairly certain the milestones will be reached or they would have pushed them out to Q1 of 2016.